Instructor in Medicine, Joslin Diabetes Center

Endocrinology

Dr. Lyle D. Mitzner, MD


Dr. Lyle D. Mitzner is an expert in the field of Endocrinology. He went to medical school at Albert Einstein College of Medicine of Yeshiva University. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Diabetes Recognition Program". Lyle Mitzner is a published MD. He has 2 publications published. The most current publication "High bone density due to a mutation in LDL-receptor-related protein 5." He accepts Medicare payments and is listed with Medicare.gov.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1619924941
NPPES Provider LastName   MITZNER
NPPES Provider FirstName   LYLE
NPPES Provider ZIPCode   022155306
NPPES Provider State   MA
Specialty Description   Endocrinology
Total Claim Count   3582.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1619924941
Last Name Of The Provider MITZNER
First Name Of The Provider LYLE
View All

Similar Doctors


Dr. Anand Vaidya, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Frances J. Hayes, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Elizabeth C. Bashoff, MD
This Doctor is OpenDoctor Recommended.
Dr. Giuseppe Barbesino, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Karla M. Pou, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Rachael L. Fawcett, MD
This Doctor is OpenDoctor Recommended.
Dr. Jason L. Gaglia, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. C R. Kahn, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Ronald M. Lechan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications


Doctor Directory | TOS | twitter | FB | Angel | blog